AzTrials
AzTrials

Generalized Anxiety DisorderPhase 1NCT00951340

Desensitization and Cognitive Therapy in General Anxiety.

A Phase 1 study testing Cognitive behavioral therapy (CBT), Emotional processing and interpersonal therapy and Listening therapy in people with Generalized Anxiety Disorder, run by Penn State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will test the feasibility and safety of adding interpersonal and emotional processing techniques to standard cognitive behavioral therapy for generalized anxiety disorder. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Generalized Anxiety Disorder
What is being tested?
Cognitive behavioral therapy (CBT), Emotional processing and interpersonal therapy and Listening therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteUnited States
Study dates
Jul 1996to Dec 1998
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Adult, Older adult

Who may be able to join

  • Principal diagnosis of generalized anxiety disorder (GAD), as defined by the DSM-IV and agreed on by two diagnostic interviewers

Who cannot join

  • Concurrent psychosocial therapy or past adequate dosage of CBT
  • Medical contributions to anxiety
  • Current substance abuse, psychosis, or organic brain syndrome

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Pennsylvania State University

    University Park, Pennsylvania, 16802-3103

Other trials in United States

About this study

This study will test the feasibility and safety of adding interpersonal and emotional processing techniques to standard cognitive behavioral therapy for generalized anxiety disorder.

Read the detailed description

Generalized anxiety disorder (GAD) is characterized by chronic worry that interrupts normal functioning. Some research has shown cognitive behavioral therapy (CBT) as an effective treatment for GAD, but only half of people treated with CBT for GAD experience treatment benefits long-term. Standard CBT for GAD may lose effectiveness over time because it does not address interpersonal and emotional processing problems. This study will determine the safety and feasibility of training therapists to deliver a version of CBT with additional therapeutic techniques for addressing interpersonal interactions and emotional processing.

Participation in this study will include 14 weekly, 2-hour, individual therapy sessions. During the first hour of each session, all participants will receive standard CBT for GAD. Participants will be randomly assigned to receive one of two therapies during the second hour: training in interpersonal and emotional processing techniques or listening therapy. Participants taking medications will be required to maintain a fixed dosage and keep a daily dairy of medication use, starting 2 weeks before study entry and lasting throughout treatment.

In-depth study assessments will take place at baseline and after completing the 15 weeks of therapy. Assessments will include clinical interviews, self-report questionnaires, and a physiological measurement session. Questions will pertain to anxiety symptoms, self-perceptions, emotional experience, and perceptions of the world. The physiological measurement session will involve recording bodily reactions, including brain waves, heart rate, eye movement, and breathing, while performing simple perceptual tasks. Brief psychological assessments will also follow each hour-long portion of each therapy session. Follow-up assessments conducted 6, 12, and 24 months after completing treatment will involve interviews and questionnaires as well as recording a week's worth of medication diaries.

Being tested
Cognitive behavioral therapy (CBT), Emotional processing and interpersonal therapy, Listening therapy
Keywords
CBT, Emotional-Focused Therapy, Interpersonal Therapy
Medical subject headings
Generalized Anxiety Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive behavioral therapy (CBT)Other

    Also called CBT for GAD

    15 weekly therapy sessions, the first hour of which will be devoted to standard CBT techniques

  • Emotional processing and interpersonal therapyBehavioural

    15 weekly therapy sessions, the second hour of which will be devoted to interpersonal and emotional processing therapy techniques

  • Listening therapyBehavioural

    15 weekly therapy sessions, the second hour of which will be directed by the participant's questions and discussion

Study groups in NCT00951340
Study groupRoleWhat they receive
CBT with listening therapyActive comparatorParticipants will receive CBT with listening therapy.
Receives: Other: Cognitive behavioral therapy (CBT); Behavioral: Listening therapy
CBT with emotional processing and interpersonal therapyExperimentalParticipants will receive CBT with emotional processing and interpersonal therapy.
Receives: Other: Cognitive behavioral therapy (CBT); Behavioral: Emotional processing and interpersonal therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of delivering emotional processing and interpersonal therapeutic techniques

    Measured: Measured at baseline, post-treatment, and after 6, 12, and 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2009 (estimated)
  2. Study startJul 1996
  3. Primary completionJul 1998
  4. Study completionDec 1998

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00951340
Sponsor's protocol ID
R01MH039172-02
Other IDs
R01MH039172-02, 2R01MH039172-12
Status last verified
Sep 2017
First submitted
3 Aug 2009
Last updated
20 Sep 2017
Results posted
No
Data monitoring committee
No

Publications

  • Newman MG, Castonguay LG, Borkovec TD, Fisher AJ, Nordberg SS. AN OPEN TRIAL OF INTEGRATIVE THERAPY FOR GENERALIZED ANXIETY DISORDER. Psychotherapy (Chic). 2008 Jun 1;45(2):135-147. doi: 10.1037/0033-3204.45.2.135.

    PubMed 19881891

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Cognitive behavioral therapy (CBT), Emotional processing and interpersonal therapy and Listening therapy in people with Generalized Anxiety Disorder, run by Penn State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of delivering emotional processing and interpersonal therapeutic techniques (time frame: Measured at baseline, post-treatment, and after 6, 12, and 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00951340, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in